CRISPR THERAPEUTICS AG (CRSP) Stock Balance Sheet
USA - NASDAQ:CRSP - CH0334081137 - Common Stock
62.56 USD
-1.61 (-2.51%)
62.38 USD
-0.18 (-0.29%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 193.62M | 298.26M | 389.48M | 211.90M | 923.00M | |||
| Marketable Securities | 1.53B | 1.61B | 1.30B | 1.60B | 1.46B | |||
| Receivables | 0.00 | 25.00M | 200.00M | 0.00 | 300.00K | |||
| Other Current Assets | 12.43M | 8.31M | 14.39M | 37.70M | 38.10M | |||
| Total Current Assets | 1.73B | 1.94B | 1.91B | 1.85B | 2.42B | |||
| Non-Current Assets | ||||||||
| PPE Net | 262.57M | 277.55M | 305.94M | 320.60M | 312.00M | |||
| Investments And Advances | N/A | 0.00 | 1.97M | 53.10M | N/A | |||
| Intangibles | N/A | 0.00 | 16.00K | 100.00K | 100.00K | |||
| Other Non-Current Assets | 33.48M | 27.35M | 13.57M | 16.30M | 22.20M | |||
| Total Non-Current Assets | 296.05M | 304.90M | 321.49M | 390.10M | 334.40M | |||
| TOTAL ASSETS | 2.03B | 2.24B | 2.23B | 2.24B | 2.75B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 91.77M | 58.36M | 60.96M | 93.50M | 103.20M | |||
| Accounts Payable | 9.75M | 14.71M | 38.15M | 27.40M | 14.80M | |||
| Other Current Liabilities | 2.84M | 14.71M | 9.68M | 200.00K | 1.90M | |||
| Total Current Liabilities | 104.36M | 87.78M | 108.79M | 121.10M | 119.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 214.22M | 222.17M | 237.98M | 246.50M | 232.50M | |||
| Total Non-Current Liabilities | 214.22M | 222.17M | 237.98M | 246.50M | 232.50M | |||
| TOTAL LIABILITIES | 318.59M | 309.95M | 346.77M | 367.60M | 352.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.71B | -1.37B | -999.70M | -846.10M | -195.90M | |||
| Additional Paid In Capital | 3.41B | 3.29B | 2.88B | 2.73B | 2.60B | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 2.79M | 2.70M | 2.50M | 2.40M | 2.40M | |||
| Treasury Stock | -62.00K | -62.00K | -62.00K | -100.00K | -100.00K | |||
| Other Shareholders' Equity | 4.04M | 1.84M | 1.91M | -15.60M | -5.10M | |||
| Shares Outstanding | 88.38M | 85.74M | 80.04M | 78.50M | 77.00M | |||
| Tangible Book Value per Share | 19.36 | 22.53 | 23.52 | 23.89 | 31.16 | |||
| Total Shareholders' Equity | 1.71B | 1.93B | 1.88B | 1.88B | 2.40B | |||
| TOTAL LIABILITIES AND EQUITY | 2.03B | 2.24B | 2.23B | 2.24B | 2.75B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 16.61 | 22.07 | 17.54 | 15.30 | 20.16 | |||
| Return On Assets (ROA) | -23.05% | -16.34% | -6.89% | -28.99% | 13.73% | |||
| Return On Equity (ROE) | -27.34% | -18.96% | -8.16% | -34.67% | 15.74% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 11.21% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 25.09% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | 25.09% | |||
All data in USD , ROIC based on taxRate of 0.21